Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 2, 2018
[ Tue, Oct 02nd 2018
] - WOPRAI
[ Tue, Oct 02nd 2018
] - WOPRAI
[ Tue, Oct 02nd 2018
] - WOPRAI
[ Tue, Oct 02nd 2018
] - WOPRAI
Mon, October 1, 2018
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
Olivia Brayer Initiated (ALNY) at Buy and Held Target at $135 on, Oct 1st, 2018
Olivia Brayer of Cantor Fitzgerald, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $135 on, Oct 1st, 2018.
Olivia has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 1 agrees with Olivia's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $87 on, Friday, September 28th, 2018
These are the ratings of the 6 analyists that currently disagree with Olivia
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $117 on, Thursday, September 13th, 2018
- Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
- Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $125 on, Monday, August 13th, 2018
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018
- Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018
